10 Best Stocks Under $10 That Could Triple
In this article, we will take a look at some of the best stocks under $10 that currently offer an upside potential of at least 200%.
Verastem Inc. (VSTM)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 7,024,000 | $26,831,680 | +53% | 0.33% |
| 2. | Deep Track Capital David Kroin | 5,740,850 | $21,930,047 | 0.32% | |
| 3. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 3,584,820 | $13,694,012 | 0.45% | |
| 4. | Stonepine Capital Timothy P. Lynch | 3,349,627 | $12,795,575 | +2% | 7.22% |
| 5. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,499,338 | $9,547,471 | +328% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.84 | 2,000 | $7,680.00 | 2,000 | 2017-09-05 | Filing | |
| $2.17 | 50,000 | $108,500.00 | 218,000 | 2020-12-04 | Filing | |
| $3.21 | 33,000 | $105,930.00 | 168,000 | 2019-03-15 | Filing | |
| $7.31 | 5,000 | $36,550.00 | 135,000 | 2018-09-28 | Filing | |
| $7.30 | 3,000 | $21,900.00 | 10,700 | 2018-09-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.00 | 44,121 | $352,968.00 | 652,712 | 2026-10-01 | Filing | |
| $8.00 | 2,566 | $20,528.00 | 123,781 | 2026-10-01 | Filing | |
| $7.70 | 55 | $423.50 | 118,014 | 2026-09-21 | Filing | |
| $5.81 | 1,302 | $7,564.62 | 589,940 | 2026-08-03 | Filing | |
| $4.18 | 20,871 | $87,240.78 | 591,242 | 2026-06-22 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 699,828 | $5,633,615 | 0.16% | |
| 2. | 19,745 | $160,130 | 0% | |
| 3. | 710 | $5,716 | 0% | |
| 4. | 586 | $4,717 | 0% | |
| 5. | 529 | $4,258 | 0% |
News See All
9 Best Small-Cap Growth Stocks to Invest In Now
In this article, we will look at the 9 Best Small-Cap Growth Stocks to Invest In Now.
10 Best Stocks Under $10 Offering More Than 50% Upside
In this article, we will take a look at some of the best stocks under $10 that are currently offering upside potential in excess of 50%.
Is Verastem, Inc. (VSTM)’s KRAS-Targeted Combination Therapy a Breakthrough for Pancreatic Cancer?
We recently compiled a list of the 10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds. Verastem, Inc. (NASDAQ:VSTM) is one of the most promising stocks on our list.
10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds
In this article, we will be taking a look at the 10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds.
Verastem, Inc. (NASDAQ:VSTM) Q1 2026 Earnings Call Transcript
Verastem, Inc. (NASDAQ:VSTM) Q1 2026 Earnings Call Transcript May 7, 2026Verastem, Inc. beats earnings expectations. Reported EPS is $-0.37, expectations were $-0.46.
Verastem, Inc. (NASDAQ:VSTM) Q4 2025 Earnings Call Transcript
Verastem, Inc. (NASDAQ:VSTM) Q4 2025 Earnings Call Transcript March 4, 2026Verastem, Inc. misses on earnings expectations. Reported EPS is $-0.5 EPS, expectations were $-0.49.
Verastem, Inc. (NASDAQ:VSTM) Q3 2025 Earnings Call Transcript
Verastem, Inc. (NASDAQ:VSTM) Q3 2025 Earnings Call Transcript November 4, 2025Verastem, Inc. misses on earnings expectations. Reported EPS is $-1.35 EPS, expectations were $-0.51.
Verastem, Inc. (VSTM) Delivers Positive Preliminary Data for VS-7375 in Mutant Solid Tumors Treatment
Verastem, Inc. (NASDAQ:VSTM) is one of the top long-term biotechnology stocks to buy. On October 23, Verastem, Inc.
Top 8 Long-Term Biotechnology Stocks to Buy
In this article, we will examine the Top 8 Long-Term Biotechnology Stocks to Buy. Momentum in biotechnology stocks is accelerating after years of underperformance.
Hedge Fund Resource Center